 |
The Pulse with Mary DelaneyAuthor: Mary Delaney
Alera Groups podcast series, The Pulse, will help you keep pace with whats trending in employee benefits. Every month, nationally recognized subject matter experts from the health and pharmacy industry and top academic and research institutions will provide data-driven insights while giving you actionable, scalable, strategies. If you are looking to reduce medical and pharmacy spend while driving better health outcomes, this podcast series is for you! Language: en-us Genres: Health & Fitness, Medicine, Mental Health Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
The Evolution of Obesity Care: What Have We Learned in the GLP-1 Era?
Episode 8
Wednesday, 16 September, 2026
In this episode of The Pulse in 15, Mary reconnects with Dr. Sean Hashmi, a leader in Lifestyle and Obesity Medicine at Kaiser Permanente, to explore how obesity treatment has evolved since their first discussion in 2022. At that time, GLP-1 medications were just beginning to gain attention. Today, they have transformed conversations around obesity management, healthcare costs, long-term outcomes, and employer health plan strategy. Dr. Hashmi shares what real-world experience has taught us about sustainable success, long-term use, and medication discontinuation, while providing practical insights for employers evaluating obesity care programs. Key Takeaways Understand how obesity treatment has evolved since GLP-1 medications entered mainstream clinical practice. Explore what providers are seeing regarding long-term outcomes, sustainability, and measures of success beyond weight loss. Gain insight into whether patients can successfully transition off GLP-1 medications and maintain their results. Identify the key elements employers should consider when developing an obesity management strategy that extends beyond medication coverage alone.
